ANRO
Price
$3.14
Change
+$0.02 (+0.64%)
Updated
Aug 15 closing price
Capitalization
85.01M
CRSP
Price
$59.73
Change
+$0.91 (+1.55%)
Updated
Aug 15 closing price
Capitalization
5.43B
74 days until earnings call
Interact to see
Advertisement

ANRO vs CRSP

Header iconANRO vs CRSP Comparison
Open Charts ANRO vs CRSPBanner chart's image
Alto Neuroscience
Price$3.14
Change+$0.02 (+0.64%)
Volume$58.68K
Capitalization85.01M
CRISPR Therapeutics AG
Price$59.73
Change+$0.91 (+1.55%)
Volume$3.06M
Capitalization5.43B
ANRO vs CRSP Comparison Chart in %
Loading...
ANRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANRO vs. CRSP commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANRO is a Hold and CRSP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (ANRO: $3.14 vs. CRSP: $59.73)
Brand notoriety: ANRO and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANRO: 26% vs. CRSP: 88%
Market capitalization -- ANRO: $85.01M vs. CRSP: $5.43B
ANRO [@Biotechnology] is valued at $85.01M. CRSP’s [@Biotechnology] market capitalization is $5.43B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANRO’s FA Score shows that 1 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • ANRO’s FA Score: 1 green, 4 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, ANRO is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANRO’s TA Score shows that 4 TA indicator(s) are bullish while CRSP’s TA Score has 4 bullish TA indicator(s).

  • ANRO’s TA Score: 4 bullish, 5 bearish.
  • CRSP’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ANRO and CRSP are a bad buy in the short-term.

Price Growth

ANRO (@Biotechnology) experienced а +2.28% price change this week, while CRSP (@Biotechnology) price change was +8.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.90%. For the same industry, the average monthly price growth was +26.70%, and the average quarterly price growth was +20.91%.

Reported Earning Dates

CRSP is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+9.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($5.43B) has a higher market cap than ANRO($85M). CRSP YTD gains are higher at: 51.753 vs. ANRO (-25.768). ANRO has higher annual earnings (EBITDA): -60.98M vs. CRSP (-455.24M). CRSP has more cash in the bank: 1.86B vs. ANRO (161M). ANRO has less debt than CRSP: ANRO (26.4M) vs CRSP (219M). CRSP has higher revenues than ANRO: CRSP (35M) vs ANRO (0).
ANROCRSPANRO / CRSP
Capitalization85M5.43B2%
EBITDA-60.98M-455.24M13%
Gain YTD-25.76851.753-50%
P/E RatioN/AN/A-
Revenue035M-
Total Cash161M1.86B9%
Total Debt26.4M219M12%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
80
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANROCRSP
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 11 days ago
88%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 16 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
ANRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NESRF11.900.14
+1.19%
Northern Star Resources Ltd
SUMCF8.190.03
+0.38%
Sumco Corp.
ACUT1.79-0.04
-2.19%
Accustem Sciences Inc.
HWAIF0.95-0.10
-9.95%
HealWELL AI Inc.
RMTG0.05-0.02
-25.93%
Regenerative Medical Technology Group Inc.

ANRO and

Correlation & Price change

A.I.dvisor tells us that ANRO and NUVL have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANRO and NUVL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANRO
1D Price
Change %
ANRO100%
+0.64%
NUVL - ANRO
30%
Poorly correlated
-0.99%
XTLB - ANRO
27%
Poorly correlated
-0.70%
NTLA - ANRO
24%
Poorly correlated
+0.83%
CRSP - ANRO
24%
Poorly correlated
+1.55%
CGON - ANRO
23%
Poorly correlated
-1.00%
More

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with RXRX. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
+1.55%
RXRX - CRSP
69%
Closely correlated
+2.30%
BEAM - CRSP
67%
Closely correlated
+1.08%
NTLA - CRSP
64%
Loosely correlated
+0.83%
CRBU - CRSP
60%
Loosely correlated
-1.00%
PRME - CRSP
58%
Loosely correlated
-1.92%
More